Clinical Trials Browser

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT03899077 2024-02-07

SAVE

Phase 2 Unknown

202 enrolled

Genitourinary

Prostatic Neoplasms

NCT04419402 2024-02-07

ENZA-p

Phase 2 Unknown

162 enrolled

Genitourinary

Metastatic Castration-Resistant Prostate Cancer

NCT05567588 2024-02-01

Pembrolizumab Plus Radiotherapy for Advanced Renal Cancer

Phase 2 Unknown

66 enrolled

Genitourinary

Clear-cell metastatic renal cell carcinoma

NCT06222125 2024-01-24

A Study of HB0025 Injection in Patients With Advanced Renal Cancer

Phase 2 Unknown

100 enrolled

Genitourinary

Kidney Neoplasms

NCT06178601 2023-12-21

A Study of RC48-ADC Combined With Cadonilimab（AK104）in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma

Phase 2 Unknown

36 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT05150236 2023-12-15

ANZUP2001

Phase 2 Unknown

93 enrolled

Genitourinary

Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT05223582 2023-12-08

Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial

Phase 2 Unknown

34 enrolled

Genitourinary

Prostatic Neoplasms

NCT06134271 2023-11-18

RASTOM

Phase 2 Unknown

160 enrolled

Genitourinary

Prostatic Neoplasms

NCT06129955 2023-11-13

Pucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell Carcinoma

Phase 2 Unknown

47 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT05555017 2023-10-06

Trace-II

Phase 2 Unknown

60 enrolled

Genitourinary

Prostatic Neoplasms

NCT05975151 2023-09-21

Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer

Phase 2 Unknown

63 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Pseudomonas Infections

NCT05979740 2023-08-31

RC48 Combined With Toripalimab and Radiotherapy for Bladder Sparing Treatment in MIBC

Phase 2 Unknown

6 enrolled

Genitourinary

Muscle Invasive Bladder Cancer

NCT05578664 2023-08-30

PE-PE

Phase 2 Unknown

81 enrolled

Genitourinary

Oligometastatic Renal Cell Carcinoma

NCT06009848 2023-08-24

Cadonilimab Plus Nab-Paclitaxel for Recurrent or Metastatic Muscle Invasive Bladder Cancer

Phase 2 Unknown

20 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT03961698 2023-08-14

MARIO-3

Phase 2 Unknown

91 enrolled

BreastGenitourinary

Breast Neoplasms, Carcinoma, Renal Cell, Triple Negative Breast Neoplasms

NCT05986981 2023-08-14

MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers

Phase 2 Unknown

20 enrolled

Genitourinary

Medullary cystic kidney disease 1, Neoplasms

NCT05900973 2023-08-07

A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancer

Phase 2 Unknown

19 enrolled

Genitourinary

Prostatic Neoplasms

NCT05879471 2023-07-24

68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Phase 2 Unknown

39 enrolled

Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT05955209 2023-07-21

Clinical Study on the Efficacy and Safety of RC48-ADC in the Treatment of Metastatic Castration Resistant Prostate Cancer (mCRPC)

Phase 2 Unknown

40 enrolled

Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT05879497 2023-07-13

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

Phase 2 Unknown

40 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT05879510 2023-07-13

68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

Phase 2 Unknown

63 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT03940235 2023-06-28

RADIOSA

Phase 2 Unknown

150 enrolled

Genitourinary

Oligometastatic Prostate Cancer

NCT05902377 2023-06-15

68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma

Phase 2 Unknown

46 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT05895864 2023-06-09

Utidelone Treated for the Recurrent or Metastatic Urothelial Carcinoma

Phase 2 Unknown

34 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT03741426 2023-06-07

WIRE

Phase 2 Unknown

60 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT05823246 2023-05-26

Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma

Phase 2 Unknown

66 enrolled

DermatologicGenitourinary

Carcinoma, Transitional Cell, Melanoma

NCT05877911 2023-05-26

Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion Chemotherapy

Phase 2 Unknown

110 enrolled

GenitourinaryGynecologic

Carcinoma, Ovarian Epithelial, Acute Kidney Injury

NCT05820724 2023-04-24

PSMA PET Scan and mpMRI for Prostate Cancer Detection

Phase 2 Unknown

100 enrolled

Genitourinary

Prostate Cancer Diagnosis

NCT03774901 2023-04-21

PULSE

Phase 2 Unknown

32 enrolled

Genitourinary

Penile Neoplasms

NCT03280667 2023-03-29

KEYPAD

Phase 2 Unknown

59 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04543110 2023-03-23

RADIANT

Phase 2 Unknown

16 enrolled

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT05775874 2023-03-20

A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC

Phase 2 Unknown

80 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT05429866 2023-03-08

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Phase 2 Unknown

441 enrolled

BreastDermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

NCT04931979 2023-03-01

Pembro-SRT

Phase 2 Unknown

49 enrolled

Genitourinary

Urologic Neoplasms

NCT05717660 2023-02-08

PERSIAN

Phase 2 Unknown

180 enrolled

Genitourinary

Oligometastatic Hormone Sensitive Prostate Cancer

NCT03845751 2023-01-12

ENHANCE

Phase 2 Unknown

20 enrolled

Genitourinary

Prostatic Neoplasms

NCT05249712 2023-01-03

Efficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate Cancer

Phase 2 Unknown

30 enrolled

Genitourinary

Prostatic Neoplasms

NCT04869371 2022-12-29

Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer

Phase 2 Unknown

75 enrolled

Genitourinary

Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel

NCT05445648 2022-12-28

CBPTMI

Phase 2 Unknown

65 enrolled

Genitourinary

Urinary Bladder Neoplasms

Clinical Trials

A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma

LUCIDA_2

To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer

Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamide

Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma

A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts

DART

An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer

Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer

Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)

VUBAR

SAVE

ENZA-p

Pembrolizumab Plus Radiotherapy for Advanced Renal Cancer

A Study of HB0025 Injection in Patients With Advanced Renal Cancer

A Study of RC48-ADC Combined With Cadonilimab（AK104）in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma

ANZUP2001

Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial

RASTOM

Pucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell Carcinoma

Trace-II

Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer

RC48 Combined With Toripalimab and Radiotherapy for Bladder Sparing Treatment in MIBC

PE-PE

Cadonilimab Plus Nab-Paclitaxel for Recurrent or Metastatic Muscle Invasive Bladder Cancer

MARIO-3

MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers

A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancer

68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Clinical Study on the Efficacy and Safety of RC48-ADC in the Treatment of Metastatic Castration Resistant Prostate Cancer (mCRPC)

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

RADIOSA

68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma

Utidelone Treated for the Recurrent or Metastatic Urothelial Carcinoma

WIRE

Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma

Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion Chemotherapy

PSMA PET Scan and mpMRI for Prostate Cancer Detection

PULSE

KEYPAD

RADIANT

A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Pembro-SRT

PERSIAN

ENHANCE

Efficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate Cancer

Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer

CBPTMI